Tag: Chemotherapy

Greater CRF predicts increased pre- and postexertional static sway, while chemo-induced peripheral neuropathy does not

Authors say Gem/Doce warrants further study for the treatment of BCG-naive high-risk non-muscle-invasive bladder cancer

In Phase I/II trial of durvalumab with neoadjuvant chemo, pathological complete response rates similar for Black, non-Black patients

For patients with borderline resectable pancreatic ductal adenocarcinoma, favorable overall survival seen with eight cycles of mFOLFIRINOX

Occurrence rates of hearing loss, tinnitus similar for cancer survivors who received platinum alone, taxane alone, both platinum and taxane

Overall survival longer with addition of pembrolizumab to chemo in tumors expressing PD-L1 with combined positive score of 10 or more

ctDNA-guided approach to determining the need for adjuvant therapy noninferior to standard management for recurrence-free survival

Findings seen in studies involving patients receiving chemoradiotherapy for nonmetastatic squamous cell carcinoma of head and neck

Median drug price markups across centers ranged from 120 to 630 percent

Event-free survival prolonged and percentage of patients with a pathological complete response higher with addition of nivolumab